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Abstract
Background: To indicate inefficiencies in health systems, previous studies examined regional variation in healthcare
spending by analyzing the entire population. As a result, population heterogeneity is taken into account to a limited
extent only. Furthermore, it clouds a detailed interpretation which could be used to inform regional budget allocation
decisions to improve quality of care of one chronic disease over another. Therefore, we aimed to gain insight into the
drivers of regional variation in healthcare spending by studying prevalent chronic diseases.
Methods: We used 2012 secondary health survey data linked with claims data, healthcare supply data and demographics
at the individual level for 18 Dutch regions. We studied patients with diabetes (n = 10,767) and depression (n = 3,735), in
addition to the general population (n = 44,694). For all samples, we estimated the cross-sectional relationship between
spending, supply and demand variables and region effects using linear mixed models.
Results: Regions with above (below) average spending for the general population mostly showed above (below)
average spending for diabetes and depression as well. Less than 1% of the a-priori total variation in spending was
attributed to the regions. For all samples, we found that individual-level demand variables explained 62-63% of the
total variance. Self-reported health status was the most prominent predictor (28%) of healthcare spending. Supply
variables also explained, although a small part, of regional variation in spending in the general population and
depression. Demand variables explained nearly 100% of regional variation in spending for depression and 88% for
diabetes, leaving 12% of the regional variation left unexplained indicating differences between regions due to
inefficiencies.
Conclusions: The extent to which regional variation in healthcare spending can be considered as inefficiency may
differ between regions and disease-groups. Therefore, analyzing chronic diseases, in addition to the traditional
approach where the general population is studied, provides more insight into the causes of regional variation in
healthcare spending, and identifies potential areas for efficiency improvement and budget allocation decisions.
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Background
The sustainability of healthcare systems is a common chal-
lenge for Western countries. One of the main responses is
to improve population health and quality of care, while
slowing down the expenditure growth by population health
management (PHM). PHM aims to integrate services across
healthcare, prevention, social care, welfare and public health
for a pre-specified population within the region [1]. Com-
monly, these initiatives are set-up by a network of health in-
surers, health care providers and other health organizations
that together develop interventions. These interventions in-
clude so-called citizen-centered interventions, which targets
citizens at risk and are tailored for pre-defined subpopula-
tions such as citizens who smoke, diabetes patients or
multi-morbid patients. In a number of countries, stake-
holders within specific regions have adopted the PHM
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approach. Examples are Gesundes Kinzigtal in Germany
[2], Accountable Health Communities in the USA [3] and
Dutch PHM initiatives [4, 5]. In order to develop policy to
improve efficiency and to make budget allocation decisions,
these initiatives require insight into the performance of (the
organization of) their health services. One way to inform
these decisions is to study the drivers of variation in health-
care spending between regions, as regional variation in
healthcare spending, not caused by differences in medical
need, is said to indicate inefficiency [6, 7].
Research has shown that regional variation in health-
care spending is determined by the interplay of demand
and supply factors under the influence of system factors
[8, 9]. Demand factors labeled as medical need, such as
demographics and health status, are generally considered
justifiable causes of variation in healthcare spending.
Empirical research has shown that such factors explain a
large part of the regional variation in healthcare spend-
ing (e.g. [8, 10, 11]). Regional variation as a result of sup-
ply factors (e.g. competition, capacity or physician
beliefs) is considered to be generally undesirable. In em-
pirical studies, those factors have been found to be of
varying impact, depending on the study context, or sys-
tem factors (e.g. [11, 12]). System factors such as (insur-
ance) regulation, price setting or payment methods
influence the dynamics of demand and supply.
Previous studies (e.g. [6, 10, 13]) generally examined re-
gional variation in healthcare spending studying sources
of variation that affect spending for the entire population
in a region, such as local price levels or general economic
circumstances. However, there is substantial population
heterogeneity that clouds a more detailed interpretation,
as other causes of variation might differ between disease
groups across regions. Population heterogeneity between
regions exists, for example in terms of the prevalence of
(chronic) diseases and multi-morbidities; a region may
have a relatively high prevalence for certain disease groups
and lower prevalence for others. Furthermore, the extent
to which regional differences are caused by disease sever-
ity or other patient characteristics or the level of treatment
standardization may vary between disease groups [14, 15].
These more detailed explanations remain undetected
when studying the general population only. Also, because
of lack of knowledge and data, it is complicated to control
for all relevant sources of variation in healthcare spending.
In order to inform, for instance, budget allocation deci-
sions for quality improvements or care standardization
efforts of one chronic disease over another, a more
detailed approach may be needed.
Therefore, this study aimed to gain further insight into
the sources of regional variation in healthcare spending by
zooming in on prevalent chronic diseases (disease-ap-
proach). We applied this to the context of 18 Dutch PHM
regions. We expected variation patterns to differ between
disease-groups within the population. This is in part intrin-
sically to the disease and in part in line with the degree to
which consensus is reached on how to treat a certain
disease [8, 15]. We selected two types of prevalent disease
groups: patients with diabetes and patients with depression.
We chose patients with diabetes as treatments for diabetes
are known to be highly standardized due to provider
approved general treatment decisions in the Dutch
Diabetes Federation Health Care Standard (DFHCS) and as
a consequence of the bundled payment model that was in-
troduced in 2010 [16]. We chose patients with depression
as treatments for depression are expected to be less stan-
dardized, considering the variety of treatment options and
lack of healthcare standards at a national level. Assuming
that treatment options vary in costs, we expected the group
of patients with depression to reflect more variation in
healthcare spending as compared to the group of patients
with diabetes. We showed the results of the disease-
approach in addition to the results of the traditional
approach (where the general population is studied) for each
step taken in the analysis of regional variation in spending,
which is to 1) describe the unadjusted regional variation in
healthcare spending, and 2) explore the extent to which
demand and supply factors explain regional variation in
healthcare spending.
Methods
Data sources
We used data from the Dutch Public Health Monitor
(DPHM) for the year 2012 [17]. We merged these data at
the individual level with demographic variables from Statis-
tics Netherlands and nationwide claims data which we ob-
tained from Vektis [18]. The claims data included all health
care use in 2012 that was covered by the basic health insur-
ance. The records were linked using a pseudonymized per-
sonal identification code. Furthermore, at the regional level,
we added health care supply data from the Netherlands
Institute for Health Services Research (NIVEL), the
National Institute of Public Health and the Environment
(RIVM) and the Health Care Inspectorate (IGZ). We used
2012 as reference year for all data sources. For an overview
of data and variables used, see Additional file 1.
Study population
To define the regions, we used the geographical demarca-
tion of 18 Dutch PHM initiatives [4]. We analyzed the
variation in healthcare spending across these regions,
focusing on three (sub)populations: 1) the general popula-
tion, 2) patients with diabetes, and 3) patients with depres-
sion. For a detailed description of the sample selection,
see Additional file 2.
The first sample (general population) was based on
participation in the DPHM survey (n = 138,000), since
we aimed to include health status information from that
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survey. We excluded individuals with missings on self-
reported health status (n = 82,455) and missings on the
health spending variable (n = 10,298). In addition, to cor-
rect for errors and costs in the data that are not linked
to Diagnosis Treatment Groups (DTGs) in the previous
year, we removed 1% outliers in terms of spending
(above €29,468) (n = 1,284) and negative values for
health spending (n = 1). As a result, 44,694 individuals
from the general population were included in the sam-
ple. The second study sample consisted of diabetes pa-
tients. We selected them by their participation in a
bundled payment program for diabetes care, the
Pharmacy-based Cost Group (PCG) or the DTGs refer-
ring to diabetes type II (n = 10,767), which is known to
include nearly all diabetes type II patients (Elissen A,
BiloH, Struijs J, Van Galen M, De Vries R, Luijk R, et al.
Development of a national diabetes register based on
claims data to support population health management in
the Netherlands, under review). The PCGs are – among
other variables - used in the Dutch risk equalization sys-
tem to identify risk-profiles that predict healthcare
spending in the following year [19]. PCGs aim to identify
persons with chronic diseases based on claims data of
the previous year for medication for which it is known
that they are used for that particular disease. The third
study sample was created by selecting patients with de-
pression (n = 3,735) in a similar way as the diabetes pa-
tients. We used PCGs and DTGs referring to depression.
Econometric specification
To allow for the complex structure of the data, i.e. indi-
viduals nested within regions and the skewed distribu-
tion of healthcare costs as dependent variable, we
performed multilevel analyses using linear mixed models
(LMM) with a random intercept for region effects. We
applied LMM to the log-transformed dependent vari-
able. We considered other methods and distributions:
see Additional file 3 for details on the model selection.
We specified the following eq. (1):
f log yij
 
¼ β0 þ
X
βij Xij þ
X
β0 j X0 j þ ν0 j þ εij
ð1Þ
where yij is the healthcare spending of individual i in re-
gion j, βij are the fixed effects of individual level charac-
teristics; Xij is the vector of variables at the individual
level; β0j are the fixed effects of the region level charac-
teristics; X0j is the vector of variables at the region level;
ν0j is the random intercept at the region level with
ν0j~N(0, σv
2), and εij is the residual error at the
individual level with εij~N(0, σε
2).
The outcome variable was the natural log of total curative
healthcare spending in 2012 at the individual level (see
Additional file 4). It was calculated by summing spending
on general practitioner (GP)-care, hospital and specialist
care, pharmaceutical care, physical therapy, mental health
care and other types of care (i.e. patient transport, mater-
nity care, medical aids and care abroad). It comprised all
spending within the basic health insurance package [18].
Similar to previous studies, individual characteristics
(age, gender, SES and health status) were included in the
model. These variables reflect justified causes of variation
in healthcare spending, which is also referred to as medical
need (e.g. [6]). The self-reported health status variable was
derived from the DPHM survey consisting of three levels
from bad to very good [17]. Self-reported health status is
generally considered to be a good predictor for future
health as it encompasses more than standard objective
measure of health (e.g. blood pressure, presence of disease)
and reflects preclinical diseases or worsening of diseases
[20]. In addition, using the self-reported health status in
addition to using claims data derived health status alone,
resolves the bias resulting from claims data derived health
status, which is not independent from the supply-side and
therefore may also reflect supplier-induced utilization. We
used 2008 and 2012 Diagnosis-based Cost Groups (DCGs),
which are cost-profiles of the diseases based on diagnosis
information [21] and PCGs from the Dutch risk
equalization model [19], each referring to data from previ-
ous years. Using claims data from previous years may
tackle the endogeneity issues that arise when using spend-
ing and health data from the same year [22]. The DCG
variable ranged from 0 to 13 or 15 (13 clusters for 2008
and 15 for 2012) where a higher DCG number is equal to
being in a higher cost cluster. We transformed the DCG
into dummy variables, reflecting being in either a specific
DCG or not. The PCG variable ranged from 0 to 20 or 25
(20 clusters for 2008 and 25 for 2012), where a higher
number means being in a higher cost cluster. As it was
possible for an individual to be in more PCGs at the same
time (i.e. reflecting multiple diseases), we constructed an
aggregate score from the PCG by summing the PCGs for
each individual.
Supply variables, in this study mainly about the access
to healthcare, reflecting generally unjustified variation,
were included at the individual and at the regional level.
At the individual level, we added distance to provider in
meters from Statistics Netherlands. At the regional level,
we used number of providers per 1000 population,
which we constructed using the four-digit postal codes
of providers in the Netherlands using information from
NIVEL, RIVM and IGZ.
The random intercept at the regional level in the full
model is considered to indicate variation in efficiency
between regions, as it reflects regional variation which is
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not due to the demand and supply variables and the ran-
dom error at the individual level in the model.
Statistical analyses
First, in order to gain insight in the a-priori variation of
the three samples, we showed the deviation from the
mean in percentages per region and the overall coeffi-
cient of variation (CoV; ratio of the standard deviation
and the mean) at the regional level. The a-priori regional
variation includes all justified and unjustified variation in
healthcare spending between regions.
Second, we studied the extent to which demand and
supply factors explained variation in healthcare spending
at the individual and regional level. For all samples sep-
arately, to identify the contribution of the variables to
the model, we fitted LMM models by gradually adding
groups of variables to a null model without covariates.
This strategy is common in analyzing regional variation
in healthcare spending and is previously used by e.g.
Gopffarth et al. [11] and Newhouse et al. [6]. We started
with demographics (age and gender), followed by health
status variables (first self-reported health status and then
the DCGs and PCGs). Consecutively, we added the sup-
ply variables one by one. Finally, we selected the best-fit
model based on subsequent nested fits for each sample
using the likelihood ratio test (LRT), Akaike Information
Criteria (AIC) and Bayesian Information Criterion (BIC).
We chose the more expanded model when the p-value
for the LRT < 0.01, and checked whether the AIC and
BIC corresponded accordingly. After fitting the model,
we calculated Pearson’s correlation coefficients for the
observed and predicted means of natural log of the cura-
tive healthcare spending to estimate how the predicted
means changed by adding the covariates. In addition, we
plotted the variance at each level for all samples.
Data management and analyses were performed using
SPSS Version 20 and Stata/MP 14.0.
Results
Unadjusted regional variation in healthcare spending
Figure 1 displays the unadjusted regional variation shown
as deviation from the mean in percentages per sample per
region. It includes both justified and unjustified variation in
healthcare spending. For the diabetes sample, region 13 and
4 ranked highest in spending per capita (pc). The two low-
est spending regions were 15 and 9. The depression sample
had highest spending pc in regions 17 and 11; lowest in re-
gion 15 and 9 (see Additional file 4 for more details and for
the exact levels of spending per region). Regions with above
(below) average spending for the general population mostly
showed above (below) average spending for diabetes and
depression as well. The disease-groups showed less variabil-
ity compared to the general population (CoV of 1.21). The
diabetes sample showed less variation than the depression
sample, which is reflected in the CoV of 1.03 for diabetes
and 1.16 for depression.
Variance (un)explained by demand and supply factors
Table 1 shows the model estimates for the null and the
best-fitted model for all samples. The results are shown on
the log-transformed scale. For all samples, the best-fitted
model included demand variables as demographic variables
and health status variables (both self-reported and claims
data derived). Additional file 5 illustrates that self-reported
health status explains a substantial part of healthcare
spending; the total variance decreased approximately 28%
on the log-scale. Supply variables were found to add small
but significantly on the log-scale, to the models for depres-
sion and the general population (not for diabetes). The
best-fitted depression model included distance in meters to
a physical therapist. For the general population, distance in
meters to GP, hospital and pharmacy were additionally
included. The Pearson’s correlations (Table 1) between the
overall mean in the null models and predicted mean in the
full models confirmed the influence of the covariates by
showing coefficients of 0.12 (diabetes), 0.14 (general popu-
lation) and 0.16 (depression), which was largely due to the
influence of the demand variables.
Figure 2 demonstrates the proportion of the variance
that is explained after fitting the models. A-priori, more
than 99% of the total variance was attributed to the indi-
vidual level (also see Table 1), leaving less than 1% attrib-
uted to the regional level. At the individual level, 62-63%
of the variance on the log-scale was explained by de-
mand variables. At the regional level, the covariates ex-
plained relatively more variation for the general
population and the depression sample (96% and 100%
respectively) than for the diabetes sample (88%).
Discussion
The aim of this study was to gain more in-depth insight
into regional variation in healthcare spending using preva-
lent chronic diseases. We used samples of patients with
diabetes and depression, as we expected more homogen-
eity due to treatment standardization in the first com-
pared to the latter. To our knowledge, we were the first to
apply such an approach. We found indications that levels
and sources of variation in healthcare spending seem to
differ between disease-groups. The results showed that
unadjusted regional variation in healthcare spending was
smaller for the sample of patients with diabetes, than for
patients with depression and the general population. Re-
gions with above (below) average spending for the general
population mostly showed above (below) average spend-
ing for diabetes and depression as well. A-priori, more
than 99% of the total variance was concentrated at the in-
dividual level, leaving less than 1% at the regional level.
We found that demand variables explained 62-63% of the
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total variance in healthcare spending. Self-reported health
status was the most prominent variable in the model,
explaining 28% of the variation. Supply variables added
nearly 0%, but significantly to the model in the general
population sample (distance to GP, hospital, pharmacy
and physical therapy) and the depression sample (distance
to physical therapy). For the general population and the
depression sample, the covariates in the model explained
96-100% of the variation at the regional level as opposed
to 88% for the diabetes sample.
The finding that variation in healthcare spending is
largely explained by demand factors and that the vari-
ation at the regional level is limited, is in accordance
with work from e.g. Lavergne, Barer [23] and Gopffarth,
Kopetsch [11]. Both studies were performed using a trad-
itional population-based approach and performed their
studies in similar health systems as the Netherlands. Based
on their results, both authors concluded that regional dif-
ferences in healthcare spending do not clearly reflect inef-
ficiencies. Therefore, Lavergne, Barer [23] suggests that
policy reforms should be rather targeted at system wide
efficiency improvements, than at high-spending regions.
Although the results of our study similarly showed a small
amount of variation that was left at the regional level, we
think that unexplained variance that might indicate ineffi-
ciency cannot be ruled out based on two findings. First, at
the regional level, the diabetes sample showed relatively
more unexplained variance than the other samples. This
indicates that variance at the regional level was caused by
factors outside of the model, as for example differences in
efficiency in organizations that were influenced by the dis-
ease standardization. In contrast, the other study samples
showed less variability. For the depression sample, all of
the variation was explained at the regional level. This
might be caused by variability in disease severity or treat-
ment differences between individuals within regions,
rather than across regions. Second, at the individual level,
supply variables were small, but significant in the general
population and depression sample and not in the diabetes
sample. Even though we found small regional effects, we
believe this insight is useful, as more efforts at the regional
level are expected in the near future, and therefore more
variability at the regional level may be encountered in ana-
lyses of disease-groups.
Our study has several limitations. First and most import-
ant, by using the self-reported health status variable which
we derived from the Dutch Public Health Monitor survey,
we were limited to a subsample of the nationwide patient-
level claims data. Consequently, we encountered loss of
precision in our analyses as the region sample sizes were
less than 30 for a maximum of three regions in the disease-
groups. Additionally, the external validity of this study de-
pends directly on that of the Dutch Public Health Monitor,
which shows selection bias that was corrected for by using
a weighing factor (unpublished work of Carolien vd Brink
submitted to TSG). Nevertheless, we believe that for the
purpose of this study, namely to show a method on how to
gain insight into differences between disease-groups within
and across regions, this had no substantial impact on our
conclusions. Second, controlling for supply and demand
factors in the analyses should be improved. For example,
we were not able to capture variables that inform cultural
differences between physician treatments or the level of
standardization of treatments per region. Third, due to
computational issues in STATA we could not retransform
the log-transformed healthcare spending variable and cal-
culate variance measures on the linear scale (see Additional
file 3). Interpretation of the results is therefore more diffi-
cult and less precise. Consequently, the extent to which
variance is explained might differ when measured on the
linear scale. However, and in extension to previous work
[11, 24], we used a more complex hierarchical structure to
Fig. 1 Unadjusted regional variation in healthcare spending in the general population and the disease-approach. CoV: Coefficient of Variation (ratio of
standard deviation and mean); data label: region identification number
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Table 1 LMM model estimates for the traditional approach and disease-based approach
General Dutch
population (n = 44,694)
Diabetes (n = 10,767) Depression (n = 3,735)
Model 0 Model 10 Model 0 Model 5 Model 0 Model 9
variable Beta (se) Beta (se) Beta (se) Beta (se) Beta (se) Beta (se)
intercept (patient
level)
7,64
(0,03)***
6,21
(0,03)***
8,04
(0,02)***
6,95
(0,05)***
7,72
(0,05)***
6,20
(0,08)***
demand age 0,01
(0,00)***
0,00
(0,00)***
0,01
(0,00)***
gender 0,03
(0,01)***
0,04
(0,01)***
0,03 (0,03)
self-reported health
status
fair 0,44
(0,01)***
0,31
(0,01)***
0,60
(0,04)***
poor 0,77
(0,02)***
0,59
(0,02)***
0,94
(0,05)***
claims data derived DCG 2012 1 0,90
(0,03)***
0,68
(0,03)***
0,80
(0,14)***
2 0,79
(0,02)***
0,54
(0,04)***
0,75
(0,08)***
3 0,81
(0,02)***
0,60
(0,04)***
0,78
(0,10)***
4 1,02
(0,02)***
0,81
(0,03)***
1,05
(0,07)***
5 1,09
(0,02)***
0,86
(0,03)***
1,02
(0,09)***
6 1,04
(0,02)***
0,92
(0,03)***
0,97
(0,08)***
7 1,13
(0,03)***
0,99
(0,04)***
1,03
(0,13)***
8 1,30
(0,06)***
1,06
(0,11)***
1,37
(0,21)***
9 1,25
(0,04)***
1,08
(0,06)***
0,86
(0,18)***
10 1,38
(0,04)***
1,18
(0,07)***
1,12
(0,17)***
11 1,45
(0,12)***
1,35
(0,17)***
1,07
(0,48)**
12 1,14
(0,06)***
1,04
(0,09)***
1,10
(0,29)***
13 1,83
(0,09)***
1,68
(0,14)***
1,55
(0,32)***
14 1,96
(0,31)***
1,49
(0,69)**
(omitted)
15 1,99
(0,50)***
(omitted) 2,34
(0,96)**
PCG 2012 0,250
(0,01)***
0,19
(0,01)***
0,22
(0,02)***
supply distance to care provider in meters
GP 0,00 (0,00)
pharmacy 0,00 (0,00)
hospital 0,00 (0,00)
physical therapist 0,00
(0,00)***
0,00
(0,00)***
intercept – variance at the regional level 0,02 (0,01) 0,00 (0,00) 0,01 (0,00) 0,00 (0,00) 0,04 (0,02) 0,00 (0,00)
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account for the nested structure of individuals into regions
and therefore avoided the disadvantages (i.e. ecological fal-
lacy) of an aggregate design. As this study has a descriptive
character and we did not aim to infer causally, we are
confident our conclusions hold up in a qualitative sense.
Despite these limitations, this study contributes to the
literature that aims to investigate the role of demand and
supply factors in explaining geographical variation in
health care spending. First, this study benefits from the
homogenous Dutch healthcare system. In contrast to, for
example, the US, financing structures and schemes are de-
fined at the country level in the Netherlands. Therefore,
they do not influence regional variation in healthcare
spending. In addition, as opposed to studies from the U.S.,
Dutch claims data cover roughly 95% of the population, as
private health insurance is mandatory. Second, we were
able to reduce bias that results from using claims data de-
rived health status, which was encountered in e.g.
Lavergne, Barer [23] and Wennberg, Sharp [25], by
including a self-reported health status variable from a
large health survey. Finally, by using a disease-approach,
we were able to create a more homogenous study popula-
tion in advance, which enriches the understanding of
causes of regional variation in spending between groups
within the population. To our knowledge, we are the first
to apply such an approach. It provides a novel process of
Table 1 LMM model estimates for the traditional approach and disease-based approach (Continued)
General Dutch
population (n = 44,694)
Diabetes (n = 10,767) Depression (n = 3,735)
Model 0 Model 10 Model 0 Model 5 Model 0 Model 9
variable Beta (se) Beta (se) Beta (se) Beta (se) Beta (se) Beta (se)
random error – variance at the individual
level
1,24 (0,01) 0,75 (0,01) 0,79 (0,01) 0,48 (0,01) 1,49 (0,03) 0,92 (0,02)
Postestimation
statistics
ICC 0,02 (0,01) 0,00 (0,00) 0,01 (0,00) 0,00 (0,00) 0,02 (0,01) 0,00 (0,00)
AIC 136507 114297 28054 22696 12120 10351
BIC 136533 114532 28075 22856 12139 10494
log likelihood −68250 − 57122 −14024 −11326 − 6057 − 5153
PC mean and predicted mean 0,14*** 0,12*** 0,16***
PC empirical Bayes mean 0,90*** 0,94*** 0,70***
total variance on the log-scale 1,54 0,57 0,62 0,23 2,22 0,85
total variance individual level 1,54 0,57 0,62 0,23 2,22 0,85
total variance regional level 0,00 0,00 0,00 0,00 0,00 0,00
DCG diagnosis cost group, PCG Pharmacy-based cost group, GP General Practitioner, AIC Aikaike Information Criterium, BIC Bayesian Information Criterion, PC
Pearson’s correlation; **: p-value < 0.05; ***: p-value < 0.01; re random effects
Fig. 2 Variance in healthcare spending explained by covariates in the general population and the disease-approach
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modeling regional variation in healthcare spending that
may be followed in similar future studies. The notion that
regional variation in healthcare spending might be a com-
position of different variation patterns of several disease-
groups is important when developing regional healthcare
policies. We suggest further research to investigate
whether regions are consistent over a larger set of disease-
groups and specific cost data to better interpret the results
research has shown this far. Moreover, in the coming
years data will become available to analyze the effects of
the PHM regions. Additionally, more research is needed
to fill in the gaps of regional variation that remains unex-
plained. A suggestion is to operationalize cultural differ-
ences to include in the analysis (previously mentioned by
Kopetsch and Schmitz [24]). At the individual level, cul-
tural differences might influence healthcare utilization on
the demand side and at the organizational level or phys-
ician level cultural differences may influence the supply
side. In addition, a longitudinal analysis of regional vari-
ation in healthcare spending using disease-groups might
be interesting to start unraveling the causal relationship
instead of a more descriptive analysis as used in this study.
Conclusion
The extent to which regional variation in healthcare spend-
ing can be considered as inefficiency may differ between re-
gions and disease-groups. Therefore, an approach analyzing
chronic diseases, in addition to the traditional approach,
where the general population is studied, provides more de-
tailed insight into the causes of regional variation in health-
care spending and identifies potential areas for efficiency
improvement and budget allocation decisions.
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